Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1007/s00277-007-0399-y | Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP |
| https://doi.org/10.3899/jrheum.101142 | Persistence with Anti-Tumor Necrosis Factor Therapies in Patients with Rheumatoid Arthritis: Observations from the RADIUS Registry |
| https://doi.org/10.1007/s40273-016-0474-0 | Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma |
| https://doi.org/10.1007/s00277-017-3191-7 | Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate? |
| https://doi.org/10.1093/annonc/mdw363.37 | Primary tumor sidedness impacts on prognosis and treatment outcome: results from three randomized studies of panitumumab plus chemotherapy versus chemotherapy or chemotherapy plus bevacizumab in 1st and 2nd line RAS/BRAF WT mCRC |
| https://doi.org/10.1016/j.clcc.2020.01.001 | Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers |
| https://doi.org/10.1016/j.lungcan.2021.09.002 | Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials |
| https://doi.org/10.1007/s00520-018-4399-3 | Real-world use of granulocyte colony-stimulating factor in ambulatory breast cancer patients: a cross-sectional study |
| https://doi.org/10.1002/alz.044786 | Converging evidence for a “gray‐zone” of amyloid burden and its relevance |
| https://doi.org/10.1080/17843286.2018.1563735 | Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results |
| https://doi.org/10.1007/s00428-019-02525-9 | European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects |
| https://doi.org/10.1007/s12325-019-0874-6 | Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC |
| https://doi.org/10.2217/crc-2019-0013 | Evolution of RAS Testing Over Time: Factors Influencing Mutation Rates in Metastatic Colorectal Cancer Patients |
| https://doi.org/10.1007/s00520-008-0517-y | Observational Aranesp® Survey to Investigate the Q3W Schedule (OASIS): a prospective observational study of treatment of chemotherapy-induced anaemia with every 3 weeks darbepoetin alfa |
| https://doi.org/10.2165/00019053-199711030-00001 | Pricing and Reimbursement of Pharmaceuticals in Belgium |
| https://doi.org/10.1200/jco.2005.23.16_suppl.lba8284 | Final results of a randomized, double-blind, active-controlled trial of darbepoetin alfa administered once every 3 weeks (Q3W) for the treatment of anemia in patients receiving multicycle chemotherapy |
| https://doi.org/10.1016/j.toxlet.2009.06.764 | The European IMI SAFE-T Consortium: Qualification of translational safety biomarkers |
| https://doi.org/10.1016/j.jval.2015.03.1181 | Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma |
| https://doi.org/10.2143/acb.3231 | CINACALCET FOR MANAGING SECONDARY HYPERPARATHYROIDISM IN DIALYSIS PATIENTS IN CLINICAL PRACTICE IN BELGIUM: A 16-MONTH OBSERVATIONAL STUDY (ECHO-B) |
| https://doi.org/10.1016/j.jval.2015.09.1084 | The Budget Impact of Denosumab in the Treatment of Giant Cell Tumor of the Bone (Gctb) in Belgium |
| https://doi.org/10.1016/j.jval.2015.09.1330 | A Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease in Belgium |
| https://doi.org/10.1016/j.jval.2016.09.649 | Short And Long Term Costs Associated With Different Cardiovascular Events In Belgium |
| https://doi.org/10.1080/17843286.2017.1314091 | Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium |
| https://doi.org/10.36648/2472-1646.5.2.61 | Pre-Analytical Challenges during RAS Testing: Tissue Quality and the Estimation of Neoplastic Cell Percentage |
| https://doi.org/10.1007/s40801-020-00185-9 | The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe |
| https://doi.org/10.1016/j.jval.2012.08.2139 | PCN99 Cost-Utility of Granulocyte-Colony Stimulating Factors for Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia in Breast Cancer Patients in Belgium |
| https://doi.org/10.1136/annrheumdis-2020-eular.2935 | AB0758 REAL-WORLD EFFICACY AND SAFETY OF APREMILAST IN BELGIAN PATIENTS WITH PSORIATIC ARTHRITIS: FINAL ANALYSIS OF THE MULTICENTRE, PROSPECTIVE APOLO STUDY |
| https://doi.org/10.1016/j.rhum.2021.10.163 | Diagnostic et traitement de l’ostéoporose en médecine générale en France : comparaison avec 7 autres pays européens |
| https://doi.org/10.1002/alz.045886 | Different abnormalities of electroencephalographic (EEG) markers in quiet wakefulness are related to visual hallucinations in patients with Parkinson’s and Lewy body diseases |
| https://doi.org/10.1016/0959-8049(95)95608-9 | 355 A randomized pilot clinical trial comparing 5 versus 10μg/kg filgrastim (Neupogen) after FEC chemotherapy in order to collect peripheral blood stem cells (PBSC) |
| https://doi.org/10.1016/j.jval.2011.08.1108 | PCN7 The Incidence and Outcome of Febrile Neutropenia in Different Chemotherapy Regimens for Cancer Patients in Belgium |
| https://doi.org/10.1097/01.jto.0000284338.90103.d3 | P1-240: OASIS, a prospective observation study of treatment of chemotherapy-induced anaemia with every 3 weeks Darbepoetin alfa |
| https://doi.org/10.1200/jco.2016.34.4_suppl.530 | RAS testing awareness amongst oncologists and panitumumab prescription for metastatic colorectal cancer: A European physician survey and medical records review. |
| https://doi.org/10.1002/alz.045853 | DNA methylation differences associated with peripheral biomarkers in the EMIF‐AD cohort |
| https://doi.org/10.1002/alz.045825 | Abnormalities of cortical neural synchronization mechanisms in subjects with mild cognitive impairment due to Alzheimer's disease and epileptiform‐like signatures |
| https://doi.org/10.1002/alz.045811 | Different abnormalities of electroencephalographic (EEG) markers in quiet wakefulness are related to motor visual hallucinations in patients with Parkinson’s and Lewy body diseases |
| What makes langerhans cells move: depressed migration of epidermal langerhans cells in mice lacking TNF receptor p75. | |
| https://doi.org/10.1016/j.rhum.2021.10.494 | Impact d’une mesure de la densité minérale osseuse par ostéodensitométrie sur la décision thérapeutique en médecine générale concernant le traitement par bisphosphonate oral de femmes atteintes d’ostéoporose post-ménopausique : étude IMOGENE |
| https://doi.org/10.1136/annrheumdis-2022-eular.837 | OP0119-HPR WHO ACCEPTS OR DECLINES AN INVITATION TO CARDIOVASCULAR SCREENING – A REGISTER STUDY ON PATIENTS WITH RHEUMATOID ARTHRITIS |
| https://doi.org/10.1136/annrheumdis-2022-eular.1974 | OP0120-HPR IMPACT OF DIFFERENT TYPES OF PHYSICAL ACTIVITY PROGRAMS ON ANKYLOSING SPONDYLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| https://doi.org/10.1007/978-3-031-14911-5_10 | Career Development for Physicians in the Biopharmaceutical Industry |
| https://doi.org/10.1016/s0960-9776(23)00123-6 | P004 Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trial |
| https://doi.org/10.1002/alz.065506 | Quantifying AD‐related brain amyloid with linearised progression models: Model‐based vs. data‐based |
| https://doi.org/10.25251/skin.7.supp.254 | Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled SPROUT Study |
| https://doi.org/10.1002/alz.071266 | Differential associations between regional amyloid PET and Alzheimer’s disease polygenic risk scores |
| https://doi.org/10.1002/alz.080072 | Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD Multimodal Biomarker Discovery study |
| https://doi.org/10.1093/rheumatology/keaf142.160 | P120 Characteristics and safety outcomes of rheumatoid arthritis patients treated with Amgevita® in the UK using data from a national register |